Pseudomonas Aeruginosa

Showing 1 - 25 of 34

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pseudomonas Aeruginosa Infections Among COVID-19 Intensive Care

Not yet recruiting
  • Pseudomonas Aeruginosa
  • COVID-19
  • Observation
  • Vandœuvre-lès-Nancy, Lorraine, France
    Nancy University Hospital
Nov 17, 2023

Bronchiectasis, Cystic Fibrosis, Pseudomonas Aeruginosa Trial (Ceftolozane/tazobactam)

Not yet recruiting
  • Bronchiectasis
  • +3 more
  • (no location specified)
Sep 6, 2023

Cystic Fibrosis Lung, Respiratory Infections, Recurrent, Chronic, Pseudomonas Aeruginosa Trial in Australia, United States

Not yet recruiting
  • Cystic Fibrosis Lung
  • +2 more
  • Tucson, Arizona
  • +14 more
Aug 24, 2023

Patients With Infection by Resistant Microorganism

Enrolling by invitation
  • Pneumonia
  • +10 more
  • Pathogen resistant phenotype
  • Sevilla, Spain
    Hospital Universitario Virgen Macarena
May 18, 2023

Non-cystic Fibrosis Bronchiectasis, Pseudomonas Aeruginosa, Lung Infection Trial in Farmington, Tyler (AP-PA02, Placebo)

Recruiting
  • Non-cystic Fibrosis Bronchiectasis
  • +2 more
  • AP-PA02
  • Placebo
  • Farmington, Connecticut
  • +1 more
Jan 13, 2023

Cystic Fibrosis, Pseudomonas Aeruginosa, Pseudomonas Trial in United States (AP-PA02, Placebo)

Active, not recruiting
  • Cystic Fibrosis
  • +4 more
  • AP-PA02
  • Placebo
  • Los Angeles, California
  • +19 more
Dec 20, 2022

Efflux Pump and Virulence Factors Genes in Pseudomonas

Not yet recruiting
  • Pseudomonas Aeruginosa
  • culture on cetrimide agar
  • +3 more
  • (no location specified)
Nov 29, 2022

Multidrug Resistant Bacterial Infection, Enterobacteriaceae Infections, Pseudomonas Aeruginosa Trial in Philadelphia (PMT)

Not yet recruiting
  • Multidrug Resistant Bacterial Infection
  • +4 more
  • Philadelphia, Pennsylvania
    Hospital of the University of Pennsylvania
Nov 17, 2022

During Pseudomonas Aeruginosa Ventilator Acquired Pneumonia

Completed
  • Pseudomonas Aeruginosa
  • Ventilation Acquired Pneumonia
    • Grenoble, Isère, France
      Medical ICU of Universitary Hospital of Grenoble
    Nov 7, 2022

    Isolation of Human Recombinant Therapeutic Monoclonal

    Recruiting
    • Pseudomonas Aeruginosa
    • Multi-antibiotic Resistance
    • Isolation of anti-Pseudomonas antibodies from type B lymphocytes
    • Grenoble, France
      Chu Grenoble Alpes
    May 6, 2022

    Carbapenem-resistant Pseudomonas Aeruginosa: the SAMPAN Study.

    Recruiting
    • Pseudomonas Aeruginosa
    • +2 more
      • Jakarta, Indonesia
      • +2 more
      Mar 22, 2022

      Carbapenem-Resistant Enterobacteriaceae Infection, Bloodstream Infection, Severe Infection Trial in Brazil (Duration of therapy)

      Recruiting
      • Carbapenem-Resistant Enterobacteriaceae Infection
      • +9 more
      • Duration of therapy
      • Feira De Santana, Bahia, Brazil
      • +18 more
      Jan 27, 2022

      Pseudomonas Aeruginosa, Pneumonia, Hematologic Malignancy Trial in New York (Ceftolozane / Tazobactam Injection)

      Suspended
      • Pseudomonas Aeruginosa
      • +2 more
      • Ceftolozane / Tazobactam Injection
      • New York, New York
        Weill Cornell Medicine
      Jan 25, 2022

      Pseudomonas Aeruginosa, Cystic Fibrosis Trial in Tallin, Yaroslavl (Tobramycin inhalation powder)

      Completed
      • Pseudomonas Aeruginosa
      • Cystic Fibrosis
      • Tobramycin inhalation powder
      • Tallin, Estonia
      • +1 more
      May 7, 2021

      Pulmonary Infections, Pseudomonas Aeruginosa Trial in Worldwide (Tobramycin inhalation powder)

      Completed
      • Pulmonary Infections
      • Pseudomonas Aeruginosa
      • Tobramycin inhalation powder
      • Pleven, Bulgaria
      • +16 more
      May 6, 2021

      Pseudomonas Aeruginosa Biofilms in Exacerbations in

      Recruiting
      • Bronchiectasis
      • +3 more
      • Microbial biofilm diagnose
      • Barcelona, Spain
        Hospital Clinic de Barcelona
      Mar 16, 2021

      Pseudomonas Aeruginosa Trial in Worldwide (MEDI3902, Placebo)

      Completed
      • Pseudomonas Aeruginosa
      • Englewood, Colorado
      • +77 more
      Jan 19, 2021

      Patients With Complicated Urinary Tract Infections Caused by P. Aeruginosa, Pseudomonas Aeruginosa, Pseudomonas Infections Trial

      Unknown status
      • Patients With Complicated Urinary Tract Infections Caused by P. Aeruginosa
      • +3 more
      • Ftortiazinon (tablets 300 mg) 1/2 dose +placebo+ Maxipim
      • +2 more
      • Saint Petersburg, Russian Federation
      • +4 more
      Jan 13, 2021

      Methicillin-resistant Staphylococcus Aureus, Clostridium Difficile, Pseudomonas Aeruginosa Trial in Baltimore, Philadelphia

      Not yet recruiting
      • Methicillin-resistant Staphylococcus Aureus
      • +2 more
      • Baltimore, Maryland
      • +1 more
      Nov 20, 2019

      Cross Transmissions of Pseudomonas Aeruginosa Between Children

      Unknown status
      • Cystic Fibrosis
      • +2 more
        • Brussels, Belgium
          Hôpital Universitaire Des Enfants Reine Fabiola
        Apr 9, 2019

        Ceftolozane-tazobactam for MDR Pseudomonas Infections

        Unknown status
        • Pseudomonas Infections
        • Pseudomonas Aeruginosa
        • Philadelphia, Pennsylvania
          Temple University, School of Pharmacy
        Apr 17, 2018

        Cystic Fibrosis, Infection, Pseudomonas Aeruginosa Trial in Uppsala (Anti-pseudomonas IgY gargle)

        Completed
        • Cystic Fibrosis
        • +2 more
        • Anti-pseudomonas IgY gargle
        • Uppsala, Sweden
          Cystic fibrosis centre,Children´s University Hospital
        Aug 31, 2016

        Alternating Inhaled Antibiotic Therapies

        Completed
        • Cystic Fibrosis
        • Pseudomonas Aeruginosa
          • Indianapolis, Indiana
            Indiana University
          Nov 5, 2015

          The Carrier Rates of Pseudomonas Aeruginosa in Family Members of

          Completed
          • Pseudomonas Aeruginosa
          • Cystic Fibrosis
            • Syracuse, New York
              SUNY Upstate Medical University
            May 29, 2015